Psoriasis Trials in Skokie, United States
Conditions / Psoriasis / Skokie, United States
Clinical trials for Psoriasis investigate a range of treatment strategies and patient populations.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00454701 | Assessment and Tracking of Long-term Alefacept Safety | TERMINATED | — |
| NCT03540160 | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) | TERMINATED | PHASE3 |
| NCT06846541 | Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02203032 | A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab | COMPLETED | PHASE3 |
| NCT03047395 | A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) | COMPLETED | PHASE3 |
| NCT00508547 | Psoriasis Longitudinal Assessment and Registry | ACTIVE_NOT_RECRUITING | — |
| NCT03090100 | A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis | COMPLETED | PHASE3 |
| NCT01163253 | A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | TERMINATED | PHASE3 |
| NCT01646177 | A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) | COMPLETED | PHASE3 |
| NCT02207244 | A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment | COMPLETED | PHASE3 |